Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Bristol-Myers Squibb buys festinavir, new NRTI active against MDR HIV

News
21 December 2010
The search for a cure

Stem cell transplant has cured HIV infection in 'Berlin patient', say doctors

News
13 December 2010
Side effects

Switching from efavirenz to etravirine improves mood and sleep

News
7 December 2010
New & experimental HIV treatments

Merck halts study of once-daily raltegravir

News
29 November 2010
New & experimental HIV treatments

Most patients in darunavir monotherapy trial stay fully suppressed

News
11 November 2010
New & experimental HIV treatments

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

News
10 November 2010
New & experimental HIV treatments

Anti-nausea drug has anti-HIV effect too

News
4 November 2010
HIV treatment for children & young people

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

News
22 October 2010
New & experimental HIV treatments

Maraviroc potentially of benefit for many patients with late HIV diagnosis

News
16 August 2010
New & experimental HIV treatments

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

News
26 July 2010
New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
New & experimental HIV treatments

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

News
20 July 2010
New & experimental HIV treatments

Merck stops development of CCR5 inhibitor vicriviroc

News
15 July 2010
The search for a cure

HIV cure efforts severely underfunded, US activists report

News
13 July 2010
HIV treatment for children & young people

Atazanavir for children approved in European Union

News
8 July 2010
New & experimental HIV treatments

Myriad halts HIV maturation inhibitor drug programme

News
8 June 2010
Vaginal rings & topical PrEP

Microbicides: the quest for user-friendly formulations

News
1 June 2010
The search for a cure

New grants for HIV cure research

News
13 May 2010
New & experimental HIV treatments

Avexa halts apricitabine development due to cash shortage

News
10 May 2010
New & experimental HIV treatments

Once-daily Kaletra approved for some treatment-experienced adults

News
29 April 2010
Changing treatment

Protease inhibitor monotherapy in clinical practice: valid option for undetectable patients

News
27 April 2010
Neurological & cognitive problems

Morphine may protect against HIV-related brain disease

News
21 April 2010